Related Experiment Video

Updated: Jul 18, 2026

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation
08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

RhoGDIbeta lacking the N-terminal regulatory domain suppresses metastasis by promoting anoikis in v-src-transformed

Takahide Ota1, Masayo Maeda, Shiho Sakita-Suto

  • 1Division of Molecular Oncology and Virology, Medical Research Institute, Kanazawa Medical University, Uchinada, Ishikawa 920-0293, Japan. takahide@kanazawa-med.ac.jp

Clinical & Experimental Metastasis
|November 18, 2006
PubMed

Insights

The RhoGDIbeta protein fragment DeltaN(1-55)RhoGDIbeta suppresses cancer metastasis by promoting anoikis, a form of programmed cell death. This fragment enhances cell adhesion but does not affect key signaling pathways involved in cancer progression.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Rho guanine nucleotide dissociation inhibitors (RhoGDIs) regulate Rho GTPase activity.
  • RhoGDIbeta is cleaved by caspases into fragments, including DeltaN(1-55)RhoGDIbeta.
  • The physiological roles of DeltaN(1-55)RhoGDIbeta, which cannot inhibit GDP dissociation, are largely unknown.

Purpose of the Study:

  • To investigate the physiological roles of the RhoGDIbeta cleavage product, DeltaN(1-55)RhoGDIbeta.
  • To explore the effects of DeltaN(1-55)RhoGDIbeta expression on cancer cell phenotypes, particularly metastasis.

Main Methods:

  • Transfection of v-src-transformed metastatic fibroblasts with plasmids expressing DeltaN(1-55)RhoGDIbeta.
  • Assessment of cell growth in vitro and metastasis in vivo.
  • Analysis of cell adhesion, lung retention, and anoikis induction.
  • Examination of signaling pathways including Rac1, Cdc42, focal adhesion kinase, p44/p42 MAPK, and Akt1.

Main Results:

  • DeltaN(1-55)RhoGDIbeta expression suppressed experimental metastasis and in vivo tumor growth.
  • Cells expressing DeltaN(1-55)RhoGDIbeta showed enhanced adhesion to extracellular matrix proteins but reduced lung retention.
  • Anoikis was promoted by DeltaN(1-55)RhoGDIbeta without altering Rac1/Cdc42 activation or key signaling pathways.

Conclusions:

  • DeltaN(1-55)RhoGDIbeta suppresses metastasis in v-src-transformed fibroblasts.
  • The mechanism involves promoting anoikis through pathways independent of Rac1, Cdc42, and focal adhesion kinase signaling.
  • Further research is needed to elucidate the precise mechanisms by which DeltaN(1-55)RhoGDIbeta induces anoikis.

More Related Videos

Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model09:03

Identification and Characterization of Metastatic Factors by Gene Transfer into the Novel RIP-Tag; RIP-tva Murine Model

Published on: October 16, 2017

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...